Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

IPA Stock Forecast, Price Targets, Chart, Dividends & Analysis

ImmunoPrecise Antibodies Ltd logo

ImmunoPrecise Antibodies Ltd

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.38
 
USD
  
-0.02
  
(-4.88%)
Previous close: 0.3995  Open: 0.3935  Bid: 0.3638  Ask: 0.4
52 week range    
0.32   
   2.60
Mkt Cap: 11 M  Avg Vol (90 Days): 536,582
Peers   
Last updated: Monday 2nd December 2024

Stock Rankings

43
MarketXLS Rank
80
Value
7
Technical
44
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

IPA Income Statement

Annual
Dec-14Dec-15Apr-17Apr-18Apr-19Apr-20Apr-21Apr-22Apr-23Apr-24
Amortization of intangibles50609.0233534.02 M4 M3 M
Basic EPS from continuing operations-0.7-0.55-6.75-2.75-3.0-1.75-0.45-0.85-1.07-1.06
Basic EPS total-0.7-0.55-6.75-2.75-3.0-1.75-0.45-0.85-1.07-1.06
Basic weighted shares outstanding110025.0110025.0792400.02 M3 M3 M16 M20 M25 M26 M
Cost of sales1 M3 M6 M6 M6 M8 M9 M12 M
Depreciation1040.0760.03 M
Depreciation unreconciled1040.0760.050609.0233534.02 M3 M3 M2 M4 M3 M
DepreciationAndAmortization1040.0760.050609.0233534.02 M3 M3 M2 M4 M3 M
Diluted EPS total-0.7-0.55-6.75-2.75-3.0-1.75-0.45-0.85-1.07-1.06
Diluted normalized net income/share-0.7-0.55-6.75-2.75-3.0-1.75-0.45-0.85-1.07-1.06
Diluted weighted shares outstanding110025.0110025.0792400.02 M3 M3 M16 M20 M25 M26 M
GainOnSaleOfSecurity3400.0-33009.0-101543.0117506.078000.0-1 M
GeneralAndAdministrativeExpense64835.031034.06 M6 M8 M8 M13 M15 M15 M16 M
Gross operating profit1 M2 M5 M8 M12 M11 M12 M12 M
ImpairmentOfCapitalAssets28500.024750.0167000.02 M15 M
Income before tax-62313.0-31852.0-5 M-5 M-8 M-5 M-6 M-16 M-28 M-29 M
Income restructuring and M&A205185.0904925.0899731.0
Income taxes-82378.0109715.04788.0-346000.01 M861000.01 M-2 M
InsuranceAndClaims39845.0185099.0135000.0748000.02 M
Interest income73004.030085.052000.0282000.0279000.0122000.023000.0
InterestExpenseNonOperating338.0240.011985.050591.0413590.01 M863000.085000.0
InterestExpenseOperating334000.0
MiscOtherSpecialCharges-160000.0332000.0331000.0
Net income from total operations-62313.0-31852.0-5 M-5 M-8 M-5 M-7 M-17 M-29 M-27 M
NetIncomeCommonStockholders-62313.0-31852.0-5 M-5 M-8 M-5 M-7 M-17 M-29 M-27 M
NetIncomeContinuousOperations-62313.0-31852.0-5 M-5 M-8 M-5 M-7 M-17 M-29 M-27 M
NetNonOperatingInterestIncomeExpense338.0240.011985.0-22413.0383505.01 M581000.0-194000.092000.04000.0
Normalized income-46300.0-23593.0-5 M-3 M-4 M-5 M-4 M-12 M-18 M-15 M
Operating income-65875.0-31794.0-5 M-5 M-6 M-4 M-4 M-17 M-26 M-14 M
Operating income before depreciation (EBITDA)-60935.0-30852.0-5 M-5 M-5 M-449000.0-1 M-12 M-21 M-23 M
OperatingExpense65875.031794.07 M7 M12 M12 M16 M28 M38 M26 M
Other income net3900.0182.0-244058.0-323182.0-1 M-82000.0-1 M631000.0-332000.0-331000.0
Other special charges-29000.0-24932.0188333.0214885.0112000.0
OtherCostofRevenue8 M9 M12 M
OtherGandA64835.031034.06 M6 M8 M8 M13 M15 M15 M16 M
OtherOperatingExpenses513000.0-2 M210000.0
PromotionAndAdvertising740000.0
RentAndLandingFees1265.01037.011323.065093.0324396.0128000.0191000.0168000.0
Research & development expense660408.0509248.0485845.0446000.02 M8 M14 M4 M
ResearchExpense8 M14 M4 M
RestructringAndMnAIncome205185.0904925.0899731.0
Revenue per share50609.0233534.02 M4 M3 M
SalariesAndWages651290.03 M5 M5 M8 M12 M
SecuritiesAmortization4231.0205185.0
Selling Gen & administrative expense64835.031034.06 M6 M9 M8 M13 M18 M19 M19 M
SellingAndMarketingExpense119192.0134680.0819250.0378000.0691000.03 M4 M4 M
Special income/charges-500.0-182.0206818.0221639.01 M160000.04000.0-167000.0-2 M-15 M
Total Income available for interest expense (EBIT)-61975.0-31612.0-5 M-5 M-7 M-4 M-5 M-16 M-28 M-29 M
Total common shares outstanding2 M2 M5 M5 M5 M5 M25 M25 M
Total net income-62313.0-31852.0-5 M-5 M-8 M-5 M-7 M-17 M-29 M-27 M
Total ordinary shares25 M25 M25 M25 M25 M25 M25 M25 M25 M25 M
Total revenues3 M5 M11 M14 M18 M19 M21 M25 M
TotalExpenses-65875.0-31794.0-8 M-10 M-17 M-18 M-22 M36 M
TotalRevenue3 M5 M11 M14 M18 M19 M21 M25 M
WriteOff18485.016454.01837.048000.04000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University